M2N Co.,Ltd (KOSDAQ:A033310) agreed to acquire an unknow stake in MYUNGMOON Pharm co.,Ltd (KOSE:A017180) on November 4, 2021. M2N Co.,Ltd has been selected as the preferred bidder.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,810 KRW | -0.18% | +3.31% | -15.36% |
03-21 | M2N Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | M2N Co.,Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-15.36% | 82.2M | |
+28.75% | 4.09B | |
+7.89% | 2.76B | |
+13.29% | 1.67B | |
-18.45% | 1.44B | |
+88.05% | 1.23B | |
+1.19% | 972M | |
+9.55% | 880M | |
+16.80% | 818M | |
-5.88% | 745M |
- Stock Market
- Equities
- A033310 Stock
- News M2N Co.,Ltd
- M2N Co.,Ltd agreed to acquire an unknow stake in MYUNGMOON Pharm co.,Ltd.